mRNA Vaccines and Therapeutics Market Revenue 2024 to 2034
mRNA Vaccines and Therapeutics Market Revenue 2024 to 2034
The mRNA vaccines and therapeutics market, at USD 19.68 billion in 2024, is forecasted to reach USD 43.60 billion by 2034, growing at 8.28% CAGR, driven by innovations in infectious and chronic disease treatments.
Report ID: 10464
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 19.68 Bn
Forecast Year,
USD 43.60 Bn
CAGR, 2025 -
8.28%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
mRNA Vaccines and Therapeutics Market Size Analysis
mRNA Vaccines and Therapeutics Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| mRNA Vaccines | 8.41 | 8.79 | 9.86 | 10.72 | 12.06 | 13.88 | 15.40 | 17.36 | 18.34 | 19.34 | 21.03 |
| mRNA Therapeutics | 11.27 | 12.52 | 13.22 | 14.27 | 14.99 | 15.42 | 16.31 | 16.98 | 18.85 | 20.92 | 22.57 |
mRNA Vaccines and Therapeutics Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Infectious Diseases | 8.27 | 9.48 | 10.36 | 10.79 | 11.36 | 13.35 | 14.85 | 16.34 | 17.25 | 18.20 | 19.22 |
| Oncology | 9.37 | 10.42 | 11.51 | 12.28 | 13.32 | 14.49 | 15.18 | 16.86 | 19.32 | 21.55 | 23.93 |
| Rare/Other | 2.03 | 1.41 | 1.20 | 1.91 | 2.38 | 1.46 | 1.69 | 1.15 | 0.62 | 0.51 | 0.45 |
mRNA Vaccines and Therapeutics Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharma & Biotech | 3.06 | 3.44 | 4.34 | 4.91 | 5.77 | 6.24 | 5.81 | 5.96 | 5.38 | 5.48 | 3.14 |
| Academic/Research | 6.98 | 7.77 | 8.18 | 8.88 | 9.69 | 10.54 | 12.41 | 13.87 | 15.29 | 16.41 | 18.94 |
| Other End-users | 9.64 | 10.10 | 10.55 | 11.19 | 11.60 | 12.51 | 13.49 | 14.51 | 16.51 | 18.38 | 21.52 |
mRNA Vaccines and Therapeutics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.30 | 5.43 | 6.43 | 6.66 | 6.25 | 6.90 | 6.76 | 6.55 | 7.28 | 8.17 | 8.19 |
| Europe | 2.63 | 2.50 | 2.45 | 3.23 | 3.70 | 4.86 | 6.71 | 8.17 | 9.09 | 8.22 | 8.83 |
| Asia Pacific | 4.49 | 5.02 | 5.15 | 5.25 | 5.60 | 5.72 | 5.46 | 6.39 | 6.26 | 6.74 | 8.30 |
| Latin America | 5.05 | 5.34 | 5.74 | 6.40 | 6.90 | 7.63 | 8.22 | 8.86 | 10.02 | 10.08 | 10.50 |
| Middle East & Africa | 2.21 | 3.02 | 3.30 | 3.44 | 4.60 | 4.19 | 4.56 | 4.37 | 4.54 | 7.06 | 7.78 |
mRNA Vaccines and Therapeutics Market
mRNA Vaccines and Therapeutics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
